Breaking News Instant updates and real-time market news.

AAVMY

ABN Amro

$0.00

(0.00%)

, BBVA

Banco Bilbao

$5.38

0.07 (1.32%)

04:55
10/19/19
10/19
04:55
10/19/19
04:55

Institute of International Finance to hold annual meeting

2019 IIF Annual Meeting will be held in Washington, D.C. on October 16-19.

AAVMY

ABN Amro

$0.00

(0.00%)

BBVA

Banco Bilbao

$5.38

0.07 (1.32%)

BCS

Barclays

$8.48

0.11 (1.31%)

BLK

BlackRock

$445.26

-5.56 (-1.23%)

BNPQY

BNP Paribas

$0.00

(0.00%)

C

Citi

$69.76

0.16 (0.23%)

CAIXY

CaixaBank

$0.00

(0.00%)

CIB

Bancolombia

$49.65

0.12 (0.24%)

CS

Credit Suisse

$12.34

0.045 (0.37%)

EV

Eaton Vance

$44.07

-0.49 (-1.10%)

GS

Goldman Sachs

$206.61

0.13 (0.06%)

HSBC

HSBC

$38.72

-0.165 (-0.42%)

JPM

JPMorgan

$120.60

0.21 (0.17%)

MA

MasterCard

$270.90

-5.74 (-2.07%)

MCO

Moody's

$217.41

-1.33 (-0.61%)

MS

Morgan Stanley

$43.70

0.25 (0.58%)

NYT

New York Times

$29.76

0.21 (0.71%)

PYPL

PayPal

$101.25

-2.38 (-2.30%)

RBS

RBS

$6.14

0.205 (3.46%)

RY

Royal Bank of Canada

$81.49

0.38 (0.47%)

SMFG

Sumitomo Mitsui

$6.87

-0.04 (-0.58%)

SPGI

S&P Global

$250.62

-2.15 (-0.85%)

STT

State Street

$63.40

3.69 (6.18%)

UBS

UBS

$11.35

0.09 (0.80%)

V

Visa

$175.83

-2.11 (-1.19%)

ZURVY

Zurich Insurance

$0.00

(0.00%)

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 06

    Nov

  • 10

    Nov

  • 12

    Nov

  • 21

    Nov

  • 04

    Dec

  • 10

    Dec

  • 07

    Jan

  • 14

    Jan

  • 14

    Jan

AAVMY ABN Amro
$0.00

(0.00%)

09/30/19
RBCM
09/30/19
DOWNGRADE
RBCM
Outperform
ABN Amro downgraded to Outperform from Top Pick at RBC Capital
RBC Capital analyst Adrian Cighi downgraded ABN Amro to Outperform from Top Pick with a price target of 21 euros, down from 23.50 euros.
09/13/19
EXAN
09/13/19
DOWNGRADE
EXAN
Neutral
ABN Amro downgraded to Neutral from Outperform at Exane BNP Paribas
Exane BNP Paribas downgraded ABN Amro to Neutral from Outperform with a price target of 19.90 euros. The firm calls ABN a "prisoner of falling rate expectations" and expects its excess capital story "should be laid to rest."
08/30/19
HSBC
08/30/19
UPGRADE
HSBC
Buy
ABN Amro upgraded to Buy from Hold at HSBC
HSBC analyst Kiri Vijayarajah upgraded ABN Amro to Buy from Hold with a price target of 22 euros, up from 21 euros.
BBVA Banco Bilbao
$5.38

0.07 (1.32%)

08/22/19
HSBC
08/22/19
UPGRADE
HSBC
Buy
Banco Bilbao upgraded to Buy from Hold at HSBC
06/26/19
SOCG
06/26/19
DOWNGRADE
SOCG
Sell
Banco Bilbao downgraded to Sell from Hold at Societe Generale
Societe Generale analyst Carlos Cabo Catena downgraded Banco Bilbao citing NIM pressure in Mexico and increased macro risks.
06/12/19
FBCO
06/12/19
DOWNGRADE
FBCO
Underperform
Banco Bilbao downgraded to Underperform from Neutral at Credit Suisse
Credit Suisse analyst Andrea Unzueta downgraded Banco Bilbao Vizcaya Argentaria to Underperform from Neutral.
04/01/19
DBAB
04/01/19
UPGRADE
DBAB
Buy
Banco Bilbao upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Ignacio Ulargui upgraded Banco Bilbao Vizcaya Argentaria to Buy from Hold and raised his price target for the shares to EUR 6.00 from EUR 4.50. The analyst sees a positive potential impact for banks from the new administration in Mexico.
BCS Barclays
$8.48

0.11 (1.31%)

11/09/18
FBCO
11/09/18
DOWNGRADE
FBCO
Neutral
Barclays downgraded to Neutral from Outperform at Credit Suisse
08/21/19
EXAN
08/21/19
UPGRADE
EXAN
Neutral
Barclays upgraded to Neutral from Underperform at Exane BNP Paribas
Exane BNP Paribas analyst Guy Stebblings upgraded Barclays to Neutral citing less material downside in US card growth and UK NIM expectations.
09/05/19
KBWI
09/05/19
UPGRADE
KBWI
Market Perform
Barclays upgraded to Market Perform from Underperform at Keefe Bruyette
BLK BlackRock
$445.26

-5.56 (-1.23%)

10/08/19
10/08/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Target (TGT) initiated with a Strong Buy at Raymond James . 2. Tyler Technologies (TYL) initiated with an Outperform rating at Oppenheimer. 3. Kirkland Lake Gold (KL) initiated with a Neutral rating at Credit Suisse. 4. Blackstone (BX) and BlackRock (BLK) initiated with a Market Perform at BMO Capital. 5. Floor & Decor (FND) initiated with a Strong Buy at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/19
KBWI
10/03/19
DOWNGRADE
Target $19.5
KBWI
Underperform
Janus Henderson downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette anlayst Robert Lee downgraded Janus Henderson Group to Underperform from Market Perform with a price target of $19.50, down from $21. The analyst sees a "challenged" organic growth outlook heading into a "seasonally weak" Q4. Amid poor investor sentiment and concerns over the direction of operating trends, he sees a re-valuation higher of stocks in the asset manager space as "highly problematic." Legg Mason (LM) and Legg Mason (BLK) are Lee's top picks into the Q3 earnings season.
10/07/19
BMOC
10/07/19
INITIATION
BMOC
KKR, Victory Capital, Apollo Global top BMO Capital picks among asset managers
BMO Capital analyst James Fotheringham initiated 11 U.S. asset managers, selecting KKR (KKR), Victory Capital (VCTR), and Apollo Global (APO) as his "top picks" with Outperform ratings and respective price targets of $40, $33, and $52 per share. The analyst believes that investors are undervaluing KKR's performance fees reliability and also have yet to appropriately value its "meaningful" excess capital. Instead, Fotheringham believes that investors are too worried about the risks of recession and KKR's relatively larger balance sheet. For Victory Global, the analyst believes that the market is overly concerned with its balance sheet leverage and believes that the company's organic growth will outperform expectations because of its exposure to to higher-growth segments like ETF products and solutions-seeking investors. For Apollo Global, Fotheringham notes that investors are undervaluing its accelerating Fee Related Earnings growth and expects the stock to benefit from technical support related to "improved liquidity, broadened shareholder engagement, and index inclusions." As part of his research note, the analyst also started the following at Market Perform: Ares Management (ARES) with price target $31, Invesco (IVZ) with price target $18, Blackrock (BLK) with price target $44, AssetMark (AMK) with price target $24, Blackstone (BX) with price target of $44, Carlyle Group (CG) with price target of $23, and T. Rowe Price (TROW) with price target of $101. Fotheringham also initiated Franklin Resources (BEN) at Underperform with price target of $16, saying the market is overvaluing its management-fee related income amid continued outflows and magnified redemption risk as well as operating expense "inflexibility". The analyst warns that Franklin's U.S. and European retail channels are facing ongoing fee pressures and risk from active-to-passive rotation.
10/07/19
BMOC
10/07/19
INITIATION
BMOC
Market Perform
BlackRock initiated with a Market Perform at BMO Capital
BNPQY BNP Paribas
$0.00

(0.00%)

04/03/19
BOFA
04/03/19
INITIATION
BOFA
Neutral
BNP Paribas reinstated with a Neutral at BofA/Merrill
BofA/Merrill reinstated coverage of BNP Paribas with an Neutral rating. The firm has a cautious view on French banks saying the need to build up capital will take many years and that 2020 targets are "uninspiring."
09/13/19
MSCO
09/13/19
DOWNGRADE
MSCO
Equal Weight
BNP Paribas downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Bruce Hamilton downgraded BNP Paribas to Equal Weight from Overweight with a price target of 50 euros, down from 57.60 euros. The analyst sees declining profitability and a tight capital path.
09/09/19
SOCG
09/09/19
DOWNGRADE
SOCG
Sell
BNP Paribas downgraded to Sell from Hold at Societe Generale
Societe Generale analyst Geoffrey Dawes downgraded BNP Paribas to Sell from Hold.
C Citi
$69.76

0.16 (0.23%)

09/24/19
MSCO
09/24/19
NO CHANGE
MSCO
Large-cap banks aren't gaining deposit market share, says Morgan Stanley
Morgan Stanley analyst Ken Zerbe said he continues to hear the "false narrative" that large-cap banks must be gaining market share due to their superior technology, but he insists they are not and that small and mid-cap banks have consistently gained deposit market share over the last five years. Individual large-cap banks that have had the biggest deposit share gains include Goldman Sachs (GS), Ally Financial (ALLY) and Synchrony Financial (SYF), while mid-cap banks that have delivered the biggest gains in share of total deposits include First Republic (FRC), KeyCorp (KEY) and Huntington (HBAN), Zerbe tells investors. Large-cap banks that have seen the largest declines in their respective individual shares of total deposits include JPMorgan (JPM), Wells Fargo (WFC) and Citigroup (C), while deposit share losers among mid-cap banks include Comerica (CMA), Prosperity Bancshares (PB) and Zions (ZION), said Zerbe.
09/06/19
BOFA
09/06/19
NO CHANGE
BOFA
BofA/Merrill sees Citi, Citizens BB&T risk/reward as 'compelling'
BofA Merrill Lynch analyst Erika Najarian said she does not believe bank stocks are pricing in a recession, though they are "bearing the brunt of cycle concerns." Bank stocks could be at a near-term bottom, said Najarian, who sees compelling risk/rewards for shares of Citi (C), Citizens Financial (CFG) and BB&T (BBT) even when taking into account theoretical fair value in a recession. Even in the case of a recession, banks have materially improved underwriting since the financial crisis and she estimates an average 46% EPS hit in a downturn but only a 5% hit in tangible book value versus consensus 2020 forecasts, Najarian tells investors.
10/16/19
BMOC
10/16/19
NO CHANGE
Target $57
BMOC
Market Perform
Wells Fargo price target lowered to $57 from $59 at BMO Capital
BMO Capital analyst James Fotheringham lowered his price target on Wells Fargo (WFC) to $57 and kept his Market Perform rating after its Q3 results. The analyst cites the bank's lower than expected net interest income along with a miss on fees and a higher than anticipated operating costs. Fotheringham contends that before the new Wells Fargo CEO arrives and administers a strategic review, there are better investment opportunities in large cap banks that include Citi (C), Bank of America (BAC), Capital One (COF) and Morgan Stanley (MS).
09/10/19
UBSW
09/10/19
DOWNGRADE
Target $49
UBSW
Neutral
Wells Fargo downgraded to Neutral from Buy at UBS
UBS analyst Saul Martinez downgraded Wells Fargo (WFC) to Neutral and lowered his price target on the stock to $49 from $51. The analyst attributes the rating change to his reduced estimates for earnings and lower net interest income along with the continued uncertainty and low visibility around the progress in the management's efficiency improvements. Martinez also cites Wells Fargo's relative valuation, with shares trading at 11.3-times expected FY20 earnings - a premium to JP Morgan's (JPM) 10.8-times, Bank of America's (BAC) 9.2-times, and Citigroup's (C) 7.9-times.
CAIXY CaixaBank
$0.00

(0.00%)

03/29/19
GSCO
03/29/19
UPGRADE
GSCO
Neutral
CaixaBank upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Jose Abad upgraded CaixaBank to Neutral from Sell citing valuation following the recent underperformance of the shares.
12/03/18
GSCO
12/03/18
DOWNGRADE
GSCO
Sell
CaixaBank downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Jose Abad downgraded CaixaBank to Sell and lowered his price target for the shares to EUR 3.50 from EUR 4.30. The analyst cites mortgage risks for the downgrade to Sell.
08/22/19
HSBC
08/22/19
UPGRADE
HSBC
Buy
CaixaBank upgraded to Buy from Hold at HSBC
07/29/19
SOCG
07/29/19
DOWNGRADE
SOCG
Hold
CaixaBank downgraded to Hold from Buy at Societe Generale
Societe Generale analyst Carlos Catena downgraded CaixaBank to Hold from Buy and lowered his price target for the shares to 2.46 euros from 3.90 euros. The analyst sees low visibility and weakening revenue momentum.
CIB Bancolombia
$49.65

0.12 (0.24%)

08/06/19
JPMS
08/06/19
UPGRADE
Target $55
JPMS
Overweight
Bancolombia upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Yuri Fernandes upgraded Bancolombia to Overweight from Neutral and raised his price target for the shares to $55 from $48. The company reported a "solid beat" in Q2 and its return on equity is moving back up to 15%, Fernandes tells investors in a research note.
10/15/19
SANT
10/15/19
UPGRADE
Target $56
SANT
Hold
Bancolombia upgraded to Hold from Underperform at Santander
Grupo Santander analyst Andres Soto upgraded Bancolombia to Hold from Underperform with a $56 price target.
08/06/19
08/06/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Northrop Grumman (NOC) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Rajeev Lalwani citing his view that an opportunity for continued outperformance exists in Defense stocks. 2. Bancolombia (CIB) upgraded to Overweight from Neutral at JPMorgan and to Neutral from Underperform at Credit Suisse. 3. Ford (F) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying Ford's partnerships and "more focused" model lineup should keep its profitability "largely stable" through 2022. 4. Aimco (AIV) upgraded to Buy from Neutral at Mizuho with analyst Haendel St. Juste saying the company trades at a "two-turn multiple discount" to peers based on estimates 2020 funds from operations as well as a 10% discount to consensus net asset value versus peers' 2% premium. 5. EverQuote (EVER) upgraded to Outperform from Market Perform at Raymond James with analyst Aaron Kessler citing the company's "strong" Q2 results and outlook. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/06/19
FBCO
08/06/19
UPGRADE
Target $53
FBCO
Neutral
Bancolombia upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst Marcelo Telles upgraded Bancolombia to Neutral from Underperform with a $53 price target. The analyst cites valuation for the upgrade following the company's Q2 results.
CS Credit Suisse
$12.34

0.045 (0.37%)

03/13/19
03/13/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Roku (ROKU) downgraded to Sell from Hold at Loop Capital and to Neutral from Outperform at Macquarie. 2. Hercules Capital (HTGC) downgraded to Market Perform from Outperform at Keefe Bruyette and to Neutral from Buy at Compass Point as well as B. Riley FBR. 3. Credit Suisse (CS) downgraded to Neutral from Overweight at JPMorgan with analyst Kian Abouhossein saying the company's investment banking strategy is "value destroying." 4. Comerica (CMA) downgraded to Neutral from Outperform at Wedbush with analyst Peter Winter saying he believes earnings growth will be more challenging in 2020 given less earnings levers, the benefit from lower expenses is behind, and share buyback activity is set to slow in 2020. 5. NuStar Energy (NS) downgraded to Underweight from Neutral at JPMorgan analyst Jeremy Tonet saying he sees lower return potential following the stock's "significant outperformance" year-to-date. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/30/19
EXAN
08/30/19
UPGRADE
EXAN
Outperform
Credit Suisse upgraded to Outperform from Neutral at Exane BNP Paribas
Exane BNP Paribas analyst Jeremy Sigee upgraded Credit Suisse to Outperform from Neutral and raised his price target for the shares to 14.20 francs from 13 francs.
08/30/19
08/30/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Abercrombie & Fitch (ANF) upgraded to Hold from Sell at Deutsche Bank with analyst Tiffany saying the company's falling margins are now reflected in its guidance. 2. DuPont (DD) upgraded to Outperform from Neutral at Exane BNP Paribas. 3. Credit Suisse (CS) upgraded to Outperform from Neutral at Exane BNP Paribas. 4. Tabula Rasa HealthCare (TRHC) upgraded to Buy from Hold at Stifel with analyst David Grossman saying the shares are trading at 4.1 times estimated 2020 revenue, which is more in line with comparable companies and a more attractive entry point, particularly given potential catalysts over the next 12-18 months. 5. CAE (CAE) upgraded to Outperform from Sector Perform at Scotiabank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/13/19
JPMS
03/13/19
DOWNGRADE
JPMS
Neutral
Credit Suisse downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Kian Abouhossein downgraded Credit Suisse to Neutral from Overweight and lowered his price target for the shares to 14 francs from 16 francs. The company's investment banking strategy is "value destroying," Abouhossein tells investors in a research note. Further, he believes Credit Suisse's cost cuts are fully discounted in the current valuation.
EV Eaton Vance
$44.07

-0.49 (-1.10%)

05/20/19
BOFA
05/20/19
DOWNGRADE
BOFA
Underperform
Eaton Vance downgraded to Underperform from Buy at BofA/Merrill
05/20/19
05/20/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. American Airlines (AAL) downgraded to Underweight from Equal Weight at Morgan Stanley while Delta Air Lines (DAL) was downgraded to Equal Weight from Overweight. 2. Deutsche Bank (DB) downgraded to Sell from Neutral at UBS with the firm saying the bank is facing limited strategic options and its operating conditions are unlikely to improve in the near term amid intense competition. 3. Eaton Vance (EV) double downgraded to Underperform from Buy at BofA/Merrill with analyst Michael Carrier lowering estimates to reflect slower flow trends, a difficult product mix, and potential margin pressures ahead. 4. ProAssurance (PRA) downgraded to Underperform from Market Perform at Keefe Bruyette with analyst Christopher Campbell saying the stock has rallied 9% since the company's "disappointing" Q1 results. 5. Clorox (CLX) downgraded to Hold from Buy at Argus with analyst John Staszak citing the company's revenue deceleration reported in Q3 to "just 2%" as well as its near-term growth outlook cut to 2%-3% from 2%-4%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/14/19
FBCO
01/14/19
NO CHANGE
Target $43
FBCO
Neutral
Eaton Vance price target lowered to $43 from $51 at Credit Suisse
Credit Suisse analyst Ari Ghosh lowered his price target for Eaton Vance to $43 from $51 ahead of quarterly results. The analyst reiterates a Neutral rating on the shares.
05/20/19
BOFA
05/20/19
DOWNGRADE
Target $37
BOFA
Underperform
Eaton Vance downgraded to Underperform on weaker growth at BofA/Merrill
As previously reported, BofA/Merrill double downgraded Eaton Vance to Underperform from Buy and cut its price target to $37 from $45. Analyst Michael Carrier lowered estimates to reflect slower flow trends, a difficult product mix, and potential margin pressures ahead. Carrier expects higher fee floating rate and alternative products to experience outflows given weak performance and macro trends.
GS Goldman Sachs
$206.61

0.13 (0.06%)

10/16/19
BMOC
10/16/19
NO CHANGE
Target $278
BMOC
Market Perform
Goldman Sachs price target raised to $278 from $273 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Goldman Sachs to $278 after its Q3 earnings beat that was driven by higher than expected Institutional Client Services revenues coming from higher equities trading results and "notably lower" compensation expenses. Despite the 37% total return implied by his price target however, the analyst is keeping his Market Perform rating on the company, saying he prefers to remain on the sidelines until the conclusion of its "front-to-back" business line review expected in January of next year as well as the potential disclosure of its new efficiency and return targets.
10/02/19
ODEN
10/02/19
NO CHANGE
ODEN
Hold
Goldman Sachs 'quite likely' to beat Q3 earnings consensus, says Odeon Capital
Odeon Capital analyst Richard Bove pointed out three reasons that he believes it is "quite likely" that Goldman Sachs will top the Q3 consensus EPS forecast of $5.41. The bank was ranked by Bloomberg as number one in U.S. equity offerings in the quarter, trading activity is likely to be higher on both a sequential and year-over-year basis and Goldman "typically" starts the process of lowering estimated compensation expenses in Q3, said Bove. Bove keeps a Hold rating on Goldman Sachs shares, noting that he thinks Goldman is unlikely to match its Q3 results in Q4.
10/14/19
KBWI
10/14/19
NO CHANGE
KBWI
Hard for Goldman, Morgan Stanley to justify E-Trade deal, says Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl looked into whether an acquisition of E-Trade (ETFC) would make sense for Goldman Sachs (GS) or Morgan Stanley (MS) after the electronic brokers reduced their commission rates. The analyst says he could make the strategic rationale for why a broker would buy an e-broker, namely cost savings and customer base expansion. However, ultimately a deal has to make sense financially as well, and it would be hard for Morgan or Goldman to justify on this basis, Kleinhanzl tells investors in a research note. In addition, with both brokers trading near tangible book value, shareholders would prefer buybacks versus an acquisition as a better use of shareholder capital at this point in the cycle, adds the analyst. As such a result, Kleinhanzl sees a deal for E-Trade as unlikely given the financial and capital impacts. He would be surprised if either broker aggressively pursued E-Trade as an acquisition.
10/16/19
OPCO
10/16/19
NO CHANGE
Target $301
OPCO
Outperform
Goldman Sachs price target lowered to $301 from $316 at Oppenheimer
Oppenheimer analyst Chris Kotowski lowered his price target for Goldman Sachs to $301 from $316 following quarterly results. The analyst reiterates an Outperform rating on the shares.
HSBC HSBC
$38.72

-0.165 (-0.42%)

07/24/19
JEFF
07/24/19
DOWNGRADE
JEFF
Hold
HSBC downgraded to Hold from Buy at Jefferies
Jefferies analyst Joseph Dickerson downgraded HSBC to Hold from Buy and lowered his price target for the shares to 6.91 pounds from 8.50 pounds. The bank needs a "new narrative" as recent short-term interest rate rises have not translated into margin improvements, Dickerson tells investors in a research note.
06/21/19
MSCO
06/21/19
DOWNGRADE
MSCO
Equal Weight
HSBC cut to Equal Weight on rate and virtual bank pressures at Morgan Stanley
As previously reported, Morgan Stanley analysts led by Anil Agarwal and Magdalena Stoklosa downgraded HSBC to Equal Weight from Overweight and cut the price target on the London-listed shares to 690p from 740p. A recent pickup in HIBOR rates should help Q2 NIMs expand meaningfully for Hong Kong banks and elevated HIBOR levels could also translate into strong NIMs in Q3, unless HIBOR retraces quickly, the team said. However, they assume two Fed rate cuts by end-2020 and think lower NIMs due to lower Fed rates, as well as the launch of virtual banks, will hurt profitability, Agarwal and Stoklosa told investors in a research note on the Hong Kong financial group. The HKMA has licensed eight virtual banks, and these, particularly the ones backed by Chinese technology players, "are likely to compete fiercely," the analysts added.
10/09/19
MSCO
10/09/19
DOWNGRADE
MSCO
Underweight
HSBC downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Magdalena Stoklosa downgraded HSBC to Underweight from Equal Weight with a price target of 540 pence. The analyst views the valuation as rich given the slowing economy in Hong Kong.
08/06/19
FBCO
08/06/19
NO CHANGE
Target $680
FBCO
Neutral
HSBC price target raised to $680 from $670 at Credit Suisse
Credit Suisse analyst Jon Peace raised his for HSBC to $680 from $670 following quarterly results. While the analyst notes that Q2 results were a little ahead of expectations on key P&L lines, a more cautious outlook relating to rates and U.S. profitability leads him to leave his forecasts largely unchanged. Peace reiterates a Neutral rating on the shares.
JPM JPMorgan
$120.60

0.21 (0.17%)

10/16/19
RBCM
10/16/19
NO CHANGE
Target $125
RBCM
Outperform
JPMorgan price target raised to $125 from $120 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on JPMorgan to $125 and kept his Outperform rating after its Q3 earnings beat driven by "strong" fixed income/currency/commodity trading business and mortgage banking results. The analyst expects JPMorgan to continue its "successful" execution, overcoming any drag related to lower interest rate spread income. Cassidy also raises his FY19 and FY20 EPS views by 19c and 36c to $10.30 and $10.85, anticipating 1-2 more interest rate cuts next year followed by the steepening in the yield curve.
10/16/19
BMOC
10/16/19
NO CHANGE
Target $126
BMOC
Market Perform
JPMorgan price target raised to $126 from $120 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on JPMorgan to $126 after its Q3 earnings beat, driven by its higher than expected fees and lower costs. The analyst also raises his FY19 and FY20 EPS views by 21c and 9c to $10.73 and $11.13 respectively but keeps his Marker Perform rating on valuation, noting that its 2-year forward price-to-earnings multiple is just slightly below its long-term historical average.
09/16/19
09/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Halliburton (HAL) downgraded to Equal Weight from Overweight at Barclays with analyst J. David Anderson saying he sees "only modest upside" to the shares after revising his estimates lower. 2. Aurora Cannabis (ACB) downgraded to Sell from Hold at Stifel with analyst W. Andrew Carter saying he sees "meaningful downside" from current share levels following the company's "disappointing" Q4 earnings release. 3. HP Inc. (HPQ) downgraded to Neutral from Buy at UBS with analyst John Roy saying he points to downside risk for the company's flat expectations in its printing supplies business amid low visibility and uncertain macro backdrop. Roy further believes that HP's PC margin would decline by more than consensus as the company passes through the component price declines and the sales mix shift away from commercial. 4. Dick's Sporting (DKS) downgraded to Market Perform from Outperform at Wells Fargo with analyst Tom Nikic saying now that Dick's has returned to positive comps and the stock has re-rated, the risk/reward is more evenly balanced. 5. JPMorgan (JPM) downgraded to Neutral from Buy at Buckingham with analyst James Mitchell citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MA MasterCard
$270.90

-5.74 (-2.07%)

09/13/19
RHCO
09/13/19
NO CHANGE
Target $325
RHCO
Buy
MasterCard price target raised to $325 from $310 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on MasterCard (MA) to $325 and kept his Buy rating, saying he expects the company to maintain its 10% or more EBITDA premium relative to Visa (V) and PayPal (PYPL). The analyst believes that MasterCard has a more durable organic revenue growth and offers a "differentiated competitive strategy" with its Real-Time Payments, adding that its monetization can be bolstered further by B2B products, cross-border payments, bill payments, point-of-sale technology, and other initiatives.
10/01/19
ADAM
10/01/19
NO CHANGE
Target $118
ADAM
Buy
PayPal payment processor deal beats card networks to China, says Canaccord
Canaccord analyst Joseph Vafi said Paypal's (PYPL) disclosure of its controlling stake in Chinese payment player GoPay has material strategic implications longer term. The analyst notes the deal allowed PayPal to beat both Visa (V) and Mastercard (MA) into the Chinese market and could be a conduit to drive meaningful cross-border payments volume allowing it to continue to sustain mid 20% payment volume for the next several years. Vafi reiterated his Buy rating and $118 price target on PayPal shares.
09/16/19
MSCO
09/16/19
NO CHANGE
Target $315
MSCO
Overweight
MasterCard price target raised to $315 from $291 at Morgan Stanley
Morgan Stanley analyst James Faucette raised his price target on MasterCard shares to $315 from $291 following the company's Investment Community Meeting last week. The intra-quarter data shared by the company should ease some near-term macro concerns and the event left him feeling confident in "the key pillars" of his Overweight thesis, Faucette tells investors. MasterCard is also making notable progress on its longer term initiatives, which should support growth beyond the company's 3-year outlook, added Faucette.
08/02/19
MSCO
08/02/19
NO CHANGE
Target $74
MSCO
Equal Weight
Square reported 'notable' deceleration in GPV, says Morgan Stanley
Morgan Stanley analyst James Faucette said the deceleration in gross payment volume, or GPV, growth reported by Square (SQ) this quarter was somewhat disappointing and "notable" given the strong U.S. consumer spending trends reported by other Payments players, including Visa (V) and MasterCard (MA). Combining this with the "deviation from Square's traditional beat-and-raise story" made him less positive about the report, although his calendar 2019 forecasts remain largely intact, said Faucette, who keeps an Equal Weight rating and $74 price target on Square shares.
MCO Moody's
$217.41

-1.33 (-0.61%)

08/05/19
ARGS
08/05/19
NO CHANGE
Target $240
ARGS
Buy
Moody's price target raised to $240 from $205 at Argus
Argus analyst John Eade raised his price target on Moody's to $240 and kept his Buy rating after its Q2 earnings beat, saying that while the stock has outperformed the S&P500 index over the past quarter, he sees "more value" in the shares. The analyst notes that Moody's is facing risks around defaults in the corporate bond market and a slowdown in corporate debt issuance, but he also expects the company to benefit from the secular trends of "global GDP growth and debt market disintermediation" over the longer term.
10/07/19
UBSW
10/07/19
UPGRADE
Target $245
UBSW
Buy
Moody's upgraded to Buy from Neutral at UBS
UBS analyst Alex Kramm upgraded Moody's to Buy from Neutral with a price target of $245, up from $215. Following two years of "lackluster" performance, the "ingredients are in place for corporate issuance to meaningfully improve," Kramm tells investors in a research note. The analyst expects the combination of low interest rates, easier compares, and "significant" corporate debt refinancing needs to drive nearly 9% ratings growth in 2020 versus the 5%-6% consensus expectations. With Moody's shares nearly 10% off their recent highs, the analyst sees an attractive entry point at current levels.
10/07/19
10/07/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Match Group (MTCH) upgraded to Buy from Neutral at Nomura Instinet and to Buy from Hold at Deutsche Bank. 2. Uber (UBER) upgraded to Buy from Neutral at Citi with analyst Itay Michaeli saying the company's upcoming Q3 results should bring an acceleration in revenue growth and swing investment sentiment more favorably. 3. Arconic (ARNC) upgraded to Overweight from Neutral at JPMorgan with analyst Seth Seifman saying he sees a "compelling" risk/reward profile following the stock's 8% decline in the past two weeks. 4. JetBlue (JBLU) upgraded to Buy from Neutral at Buckingham with analyst Daniel McKenzie saying competitive capacity looks manageable at this point, but notes that his upgrade is likely "early," given IT initiatives that don't become material to revenue until the first quarter of 2020. 5. E-Trade (ETFC) and Moody's (MCO) upgraded to Buy from Neutral at UBS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/19
JPMS
07/10/19
INITIATION
Target $220
JPMS
Overweight
Moody's initiated with an Overweight at JPMorgan
JPMorgan analyst Michael Cho started Moody's with an Overweight rating and $220 price target. Despite short-term volatility from debt issuance trends, the company has displayed "impressive" organic, constant currency revenue growth driven by pricing power, innovation and a growing end markets, Cho tells investors in a research note.
MS Morgan Stanley
$43.70

0.25 (0.58%)

10/10/19
10/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Apple (AAPL) upgraded to Buy from Neutral at Longbow with analyst Shawn Harrison saying his contacts, who previously gave him initial conservative forecasts for up to a 10% year-over-year decline in iPhone production in the calendar third quarter, now see flat production in the period of Apple's fiscal fourth quarter. 2. Qorvo (QRVO) and Skyworks (SWKS) upgraded to Outperform from Market Perform at Cowen. 3. Allegheny Technologies (ATI) upgraded to Buy from Neutral at Goldman Sachs with analyst Matthew Korn saying Allegheny is one of few stocks in the sector with sales growth that does not depend on a commodity price recovery. 4. Bed Bath & Beyond (BBBY) upgraded to Outperform from Market Perform at Telsey Advisory. 5. Morgan Stanley (MS) upgraded to Buy from Hold at Sandler O'Neill with analyst Jeffery Harte citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage click here.
10/10/19
SDLR
10/10/19
UPGRADE
Target $48
SDLR
Buy
Sandler says Morgan Stanley trading at 'unwarranted' discount, upgrades to Buy
As previously reported, Sandler O'Neill analyst Jeffery Harte upgraded Morgan Stanley to Buy from Hold with an unchanged price target of $48, citing valuation. The stock is up just 2% year-to-date, which "meaningfully" lags universal bank peers, leaving the stock trading at what he believes to be an "unwarranted" discount. The shares have risen in 15 of the last 20 fourth quarters as investor shift their from a seasonally slow quarter to the seasonally strong first quarter that will be coming, noted Harte ahead of the company's upcoming Q3 earnings report.
NYT New York Times
$29.76

0.21 (0.71%)

10/09/19
GUGG
10/09/19
INITIATION
Target $27.5
GUGG
Neutral
New York Times initiated with a Neutral at Guggenheim
Guggenheim analyst Curry Baker initiated New York Times with a Neutral rating and a price target of $27.50. The analyst notes that while the company has successfully transformed its business model into a digital, subscription-first enterprise over the past five years, it looks to be falling short on its target of reaching 10M subscribers by 2025. Baker is forecasting about 9.4M subscribers by that year, adding that New York Times stock is currently trading at a "rich premium" to its peer set and other media companies.
10/02/19
JPMS
10/02/19
NO CHANGE
Target $37
JPMS
Overweight
New York Times subscriber growth to accelerate in 2020, says JPMorgan
New York Times has successfully transformed itself into a digital growth business mitigating declines in print, JPMorgan analyst Alexia Quadrani tells investors in a research following a deep dive into the company's future outlook. She believes New York Times' subscriber growth is likely to accelerate, although with its costs remaining elevated. The analyst expects an acceleration in subscriber growth beginning in 2020, driven by the elevated news cycle around the elections and the return on investments the company has been making to broaden the product offering and better convert the casual reader to a subscriber. Its addressable market is large and competition thus far is "somewhat limited," contends Quadrani. The analyst established a December 2020 price target for the shares of $37 and raised her subscriber adds for the core news product in 2020 to 600,000 from 575,000 and digital to 275,000 from 250,000. Quadrani keeps an Overweight rating on New York Times.
12/14/18
12/14/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Outperform at Wedbush and a Hold at Deutsche Bank. 2. New York Times (NYT) initiated with an Outperform at Evercore ISI. 3. Ford (F) and General Motors (GM) were initiated with a Buy at Deutsche Bank, while Autoliv (ALV) was initiated with a Sell. 4. AstraZeneca (AZN) initiated with a Buy at SunTrust while GlaxoSmithKline (GSK) was initiated with a Hold. 5. DaVita (DVA) initiated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/09/19
10/09/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Peloton (PTON) initiated with an Outperform rating at Baird. 2. Boot Barn (BOOT) initiated with an Overweight rating at Stephens. 3. Wingstop (WING) initiated with a Buy rating at Loop Capital. 4. LexinFintech (LX) initiated with an Outperform at Credit Suisse. 5. New York Times (NYT) initiated with a Neutral at Guggenheim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
PYPL PayPal
$101.25

-2.38 (-2.30%)

10/10/19
NOMU
10/10/19
NO CHANGE
Target $139
NOMU
Buy
PayPal likely to sign more Chinese partnerships, says Nomura Instinet
On the heels of PayPal's recent GoPay acquisition, more partnerships with Chinese mobile payments players may be in the works, Nomura Instinet analyst Bill Carcache tells investors in a research note. The analyst believes the GoPay deal has raised the possibility of more "mutually beneficial partnerships" between PayPal and key players inside China's payments ecosystem. He keeps a Buy rating on the shares with a $139 price target.
10/09/19
BTIG
10/09/19
NO CHANGE
Target $130
BTIG
Buy
BTIG lowers Q3 EPS view for PayPal after projected investment losses
BTIG analyst Mark Palmer lowers his Q3 EPS view on Paypal to 54c from 69c after the company disclosed an expected 15c impact in the quarter from unrealized losses in its strategic investment portfolio. The analyst is keeping his Buy rating and $130 price target on the stock however, citing the company's "differentiated assets" and "trusted brand" sustaining its leading position in digital payments.
09/24/19
UBSW
09/24/19
NO CHANGE
Target $120
UBSW
Neutral
PayPal leads among P2P providers, app share remains stable, says UBS
UBS analyst Eric Wasserstrom is keeping his Neutral rating and $120 price target on PayPal as part of his broader research note into U.S. Payment Networks. The analyst states that his most recent UBS Evidence Lab Mobile Banking App Download data suggests that mobile payment apps continue to gain market share relative to the traditional banking apps, and within that category, remittance apps continue to lose share vs. P2P apps like Venmo. Wasserstrom adds that PayPal - while challenged by newer entrants like Square Cash - is still maintaining its leading position in P2P. The analyst maintains however that Venmo's contribution to PayPal's revenue and earnings is already reflected in the stock's premium multiple relative to its historical levels.
RBS RBS
$6.14

0.205 (3.46%)

10/01/19
LEHM
10/01/19
DOWNGRADE
LEHM
Equal Weight
RBS downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Christopher Manners downgraded RBS to Equal Weight from Overweight and lowered his price target for the shares to 2.25 pounds from 2.50 pounds. The analyst, who reduced his estimates for the U.K. banks by around 10%, sees shares of RBS underperforming in the near-term as numbers come down.
09/06/19
DBAB
09/06/19
DOWNGRADE
DBAB
Hold
RBS downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Amandeep Singh downgraded RBS to Hold from Buy with a price target of 2.15 pounds.
10/18/19
JPMS
10/18/19
UPGRADE
JPMS
Overweight
RBS upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Raul Sinha upgraded Royal Bank of Scotland to Overweight from Neutral with a price target of 280 pence, up from 210 pence. Following the developments on Brexit, domestic U.K. and Irish banks are likely to "re-rate further," even if the U.K. parliament does not vote in favor initially, as long as the probability of no deal remains low, Sinha tells investors in a research note. He thinks investors should be looking to add exposure and that RBS offers the "best re-rating potential."
10/16/19
REDB
10/16/19
UPGRADE
REDB
Neutral
RBS upgraded to Neutral from Sell at Redburn
Redburn analyst Fahed Kunwar upgraded Royal Bank of Scotland Group to Neutral from Sell.
RY Royal Bank of Canada
$81.49

0.38 (0.47%)

12/10/18
TDSI
12/10/18
UPGRADE
TDSI
Buy
Royal Bank of Canada upgraded to Buy from Hold at TD Securities
12/10/18
12/10/18
UPGRADE

Buy
Royal Bank of Canada upgraded to Buy on domestic strength at TD Securities
As previously reported, TD Securities upgraded Royal Bank of Canada to Buy from Hold with a C$115 price target. Analyst Richard Roth prefers Royal Bank's domestic market strength and diversity of its business model in periods of market uncertainty and consistent superior earnings growth.
11/29/18
ARGS
11/29/18
NO CHANGE
Target $89
ARGS
Buy
Royal Bank of Canada price target lowered to $89 from $94 at Argus
Argus analyst Stephen Biggar lowered his price target on Royal Bank of Canada to $89 after its Q1 earnings, saying the revision is mostly driven by the less favorable currency rate. The analyst also keeps his Buy rating on the bank based on its "leading positions in personal/commercial banking, capital markets, and wealth management", anticipating the company's earnings growth to outpace that of other Canadian banks. With a dividend yield over 4%, Biggar is also positive on Royal Bank of Canada's "income story", noting that its slight valuation premium is justified by its earnings growth, efficiency, and profitability metrics.
12/12/18
MACQ
12/12/18
UPGRADE
MACQ
Outperform
Royal Bank of Canada upgraded to Outperform from Neutral at Macquarie
SMFG Sumitomo Mitsui
$6.87

-0.04 (-0.58%)

11/13/18
SBSH
11/13/18
INITIATION
SBSH
Neutral
Sumitomo Mitsui initiated with a Neutral at Citi
Citi analyst Koichi Niwa started Sumitomo Mitsui with a Neutral rating.
SPGI S&P Global
$250.62

-2.15 (-0.85%)

08/02/19
BMOC
08/02/19
NO CHANGE
Target $255
BMOC
Market Perform
S&P Global price target raised to $255 from $233 at BMO Capital
BMO Capital analyst Jeffrey Silber raised his price target on S&P Global to $255 after its Q2 earnings beat and raised FY19 guidance, saying the quarter was driven by growth in its data subscription businesses along with Ratings revenue strength coming from transaction activity. The analyst adds the outlook for the company looks "incrementally more positive" this year, but keeps his Market Perform rating, noting that about half of S&P Global's business remains tied to its debt rating trends.
08/05/19
ARGS
08/05/19
NO CHANGE
Target $290
ARGS
Buy
S&P Global price target raised to $290 from $230 at Argus
Argus analyst John Eade raised his price target on S&P Global to $290 and kept his Buy rating, saying the company is completing its multiyear restructuring with growing focus on its faster-growing financial businesses, including the "lucrative and not-very-competitive business of rating bonds." The analyst also cites S&P Global's trend of consistently underpromising and overdelivering with financial results. Eade contends that ever after 5 years of steady stock price growth, he still sees value in S&P Global shares.
08/06/19
ATLE
08/06/19
DOWNGRADE
ATLE
Neutral
S&P Global downgraded to Neutral from Overweight at Atlantic Equities
08/02/19
CANT
08/02/19
NO CHANGE
Target $294
CANT
Overweight
S&P Global price target raised to $294 from $244 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi raised his price target for S&P Global to $294 from $244 saying issuance improved sequentially in Q2 after a "tough" Q1. Further, margins were up, driven by increasing efficiencies from prior product rollouts, Foresi tells investors in a research note. He reiterates an Overweight rating on S&P Global.
STT State Street
$63.40

3.69 (6.18%)

10/18/19
KBWI
10/18/19
UPGRADE
Target $64
KBWI
Market Perform
State Street upgraded to Market Perform from Underperform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl upgraded State Street to Market Perform from Underperform with a price target of $64, up from $51. State Street beat on revenues and expenses this quarter and saw stability in asset servicing fee rates, which is positive, Kleinhanzl tells investors in a research note. The analyst says that with its core fundamentals stabilized, State Street's Underperform thesis have played out.
07/08/19
MSCO
07/08/19
DOWNGRADE
MSCO
Underweight
Morgan Stanley cuts large cap banks view, double downgrades State Street, BNY
As previously reported, Morgan Stanley analyst Betsy Graseck double downgraded State Street (STT) and BNY Mellon (BK), each to Underweight from Overweight, and downgraded her industry view for large cap banks to In-Line from Attractive. The group is up 23% year-to-date, but the next 6-18 months look tougher as global GDP is slowing, inflation expectations are dimming and the Fed is expected to cut rates in 2019 and 2020, which will make it "much harder for bank stocks to deliver positive surprises in operating leverage," Graseck tells investors. While she is not double downgrading the group to Cautious, because credit remains strong, Graseck sees trust banks as most exposed to the yield curve ahead of what she foresees as "18 months of rate cuts," the analyst added. She lowered her price targets on a number of large cap banks and cut her target on State Street to $55 from $69 while dropping her target for BNY to $41 from $50.
07/08/19
07/08/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Sell from Neutral at Rosenblatt with analyst Jun Zhang citing his view that its fundamental will deteriorate over the next 6-12 months. 2. Verizon (VZ) downgraded to Neutral from Buy at Citi with analyst Michael Rollins saying rising long-term industry risks and the stock's current valuation premium are likely to limit returns over the next 12-months. 3. F5 Networks (FFIV) downgraded to Sell from Neutral at Goldman Sachs with analyst Rod Hall saying the company's earnings risks are increasing due to the weaker short-term spending environment and increasing competitive threat. 4. BNY Mellon (BK) and State Street (STT) were double downgraded to Underweight from Overweight at Morgan Stanley. 5. American Airlines (AAL) downgraded to Underperform from Neutral at Credit Suisse with analyst Jose Caiado citing labor and Boeing (BA) 737 Max risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/08/19
MSCO
07/08/19
DOWNGRADE
MSCO
Underweight
State Street downgraded to Underweight from Overweight at Morgan Stanley
Morgan Stanley analyst Betsy Graseck double downgraded State Street to Underweight from Overweight.
UBS UBS
$11.35

0.09 (0.80%)

08/30/19
EXAN
08/30/19
DOWNGRADE
EXAN
Neutral
UBS downgraded to Neutral from Outperform at Exane BNP Paribas
Exane BNP Paribas analyst Jeremy Sigee downgraded UBS to Neutral from Outperform and lowered his price target for the shares to 11.40 francs from 14.20 francs.
08/21/19
DZBN
08/21/19
DOWNGRADE
DZBN
Sell
UBS downgraded to Sell from Hold at DZ Bank
09/10/19
KPLR
09/10/19
UPGRADE
KPLR
Buy
UBS upgraded to Buy from Hold at Kepler Cheuvreux
08/30/19
08/30/19
DOWNGRADE

Fly Intel: Top analyst downgrade
Catch up on today's top analyst downgrades with this list compiled by The Fly: 1. Ulta Beauty (ULTA) downgraded to Neutral from Buy at Citi, to Neutral from Overweight at Piper Jaffray and Atlantic Equities, to Neutral from Outperform at Exane BNP Paribas, to Market Perform from Outperform at Wells Fargo, and to Equal Weight from Overweight at Morgan Stanley. 2. Toronto-Dominion (TD) downgraded to Market Perform from Outperform at BMO Capital with analyst Sohrab Movahedi saying he views the company's Q4 results as a "low-quality meet" and believes the stock's total return potential is now in line with other similarly rated banks. 3. Novo Nordisk (NVO) downgraded to Underperform from Hold at Jefferies with analyst Peter Welford saying he believes the shares at current levels are becoming expensive. 4. UBS (UBS) downgraded to Neutral from Outperform at Exane BNP Paribas. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
V Visa
$175.83

-2.11 (-1.19%)

07/24/19
RAJA
07/24/19
NO CHANGE
Target $193
RAJA
Outperform
Visa price target raised to $193 from $177 at Raymond James
Raymond James analyst John Davis raised his price target for Visa to $193 from $177 following what he views as a "solid" Q3 print that included a top and bottom line beat, EPS guidance raise, and relatively stable quarter to date trends. The analyst reiterates an Outperform rating on the shares.
ZURVY Zurich Insurance
$0.00

(0.00%)

05/31/19
HSBC
05/31/19
DOWNGRADE
HSBC
Hold
Zurich Insurance downgraded to Hold from Buy at HSBC
HSBC analyst Dhruv Gahlaut downgraded Zurich Insurance to Hold from Buy while raising his price target for the shares to 355 francs from 350 francs.
06/20/19
JPMS
06/20/19
UPGRADE
JPMS
Overweight
Zurich Insurance upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Michael Huttner upgraded Zurich Insurance to Overweight from Neutral and raised his price target for the shares to 400 francs from 365 francs.
08/20/19
JEFF
08/20/19
UPGRADE
JEFF
Buy
Zurich Insurance upgraded to Buy from Hold at Jefferies
Jefferies analyst Philip Kett upgraded Zurich Insurance to Buy from Hold as he believes it stands out as "one of the best positioned insurers" with 26% of earnings coming from "the stable, stolid and under-appreciated Farmers." In addition to Zurich's Farmers Management business, Kett said Zurich Life is already overweight protection over guarantees and the company's P&C results "are exceptional." He raised his price target on the stock to CHF380 from CHF323.
12/06/18
JPMS
12/06/18
DOWNGRADE
JPMS
Neutral
Zurich Insurance downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Michael Huttner downgraded Zurich Insurance to Neutral and lowered his price target for the shares to 359 francs from 367 francs.

TODAY'S FREE FLY STORIES

INVH

Invitation Homes

$29.95

-0.04 (-0.13%)

18:47
11/18/19
11/18
18:47
11/18/19
18:47
Hot Stocks
Invitation Homes CEO sells 70K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$369.50

-2.05 (-0.55%)

, LUV

Southwest

$57.77

-0.03 (-0.05%)

18:44
11/18/19
11/18
18:44
11/18/19
18:44
Periodicals
Boeing to provide Southwest board with 737 MAX update this week, Reuters says »

Boeing (BA) this week…

BA

Boeing

$369.50

-2.05 (-0.55%)

LUV

Southwest

$57.77

-0.03 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 23

    Jan

GBDC

Golub Capital

$17.79

0.045 (0.25%)

18:42
11/18/19
11/18
18:42
11/18/19
18:42
Upgrade
Golub Capital rating change  »

Golub Capital upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

GM

General Motors

$36.62

-0.25 (-0.68%)

, TM

Toyota

$143.53

-0.76 (-0.53%)

18:42
11/18/19
11/18
18:42
11/18/19
18:42
Periodicals
CA to halt purchase of GM, Toyota, Fiat Chrysler vehicles, Reuters reports »

The state of California…

GM

General Motors

$36.62

-0.25 (-0.68%)

TM

Toyota

$143.53

-0.76 (-0.53%)

FCAU

Fiat Chrysler

$15.63

-0.39 (-2.43%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CRMT

America's Car-Mart

$90.88

3.22 (3.67%)

, WUBA

58.com

$50.26

-1.35 (-2.62%)

18:38
11/18/19
11/18
18:38
11/18/19
18:38
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

CRMT

America's Car-Mart

$90.88

3.22 (3.67%)

WUBA

58.com

$50.26

-1.35 (-2.62%)

BILI

Bilibili

$16.39

-0.32 (-1.92%)

SAEX

SAExploration

$1.51

-0.05 (-3.21%)

CLVS

Clovis

$7.05

0.68 (10.68%)

NOW

ServiceNow

$266.56

6.65 (2.56%)

OKTA

Okta

$121.21

3.76 (3.20%)

SPLK

Splunk

$122.64

3.49 (2.93%)

WWD

Woodward

$113.64

-1.15 (-1.00%)

KRNT

Kornit Digital

$33.07

-1.13 (-3.30%)

ASH

Ashland

$78.65

0.03 (0.04%)

VNET

21Vianet

$8.28

0.23 (2.86%)

DHT

DHT Holdings

$7.52

-0.2 (-2.59%)

KRTX

Karuna Therapeutics

$94.70

77.44 (448.67%)

EGHT

8x8, Inc.

$20.78

0.13 (0.63%)

I

Intelsat

$7.98

-5.42 (-40.45%)

PFGC

Performance Food Group

$46.09

-0.08 (-0.17%)

EFC

Ellington Financial

$18.79

0.01 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 18

    Nov

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 12

    Dec

  • 16

    Dec

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

  • 21

    Nov

LEVI

Levi Strauss

$17.06

-0.115 (-0.67%)

18:31
11/18/19
11/18
18:31
11/18/19
18:31
Hot Stocks
Levi Strauss CEO: I believe in the importance of innovation »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$45.17

0.07 (0.16%)

18:17
11/18/19
11/18
18:17
11/18/19
18:17
Periodicals
Cisco sues former employees over claims of trade secret theft, Bloomberg says »

Cisco is suing two…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 12

    Feb

ABBV

AbbVie

$88.71

0.07 (0.08%)

18:09
11/18/19
11/18
18:09
11/18/19
18:09
Hot Stocks
AbbVie treatment of myelofibrosis granted FDA orphan status »

AbbVie's navitoclax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PRQR

ProQR Therapeutics

$6.27

-0.64 (-9.26%)

18:06
11/18/19
11/18
18:06
11/18/19
18:06
Hot Stocks
ProQR Therapeutics treatment of retinal dystrophy in P23H granted orphan status »

ProQR Therapeutics'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$16.39

-0.32 (-1.92%)

18:04
11/18/19
11/18
18:04
11/18/19
18:04
Earnings
Bilibili sees Q4 revenue RMB1.93B-RMB1.98B »

Q4 revenue consensus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

WUBA

58.com

$50.26

-1.35 (-2.62%)

18:03
11/18/19
11/18
18:03
11/18/19
18:03
Earnings
58.com sees Q4 revenue up 12%-15% in RMB terms »

Based on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BILI

Bilibili

$16.39

-0.32 (-1.92%)

18:03
11/18/19
11/18
18:03
11/18/19
18:03
Hot Stocks
Bilibili reports average MAUs reached 127.9M in Q3 »

Average monthly active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

WUBA

58.com

$50.26

-1.35 (-2.62%)

18:03
11/18/19
11/18
18:03
11/18/19
18:03
Earnings
58.com reports Q3 adjusted EPS 96c, consensus 82c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BILI

Bilibili

$16.39

-0.32 (-1.92%)

18:01
11/18/19
11/18
18:01
11/18/19
18:01
Earnings
Bilibili reports Q3 adjusted EPS (15c), consensus (14c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

DDOG

Datadog

$40.36

-0.33 (-0.81%)

, AMZN

Amazon.com

$1,752.70

15.21 (0.88%)

17:56
11/18/19
11/18
17:56
11/18/19
17:56
Hot Stocks
Datadog announces support for AWS CloudFormation Registry and CLI »

Datadog (DDOG) announced…

DDOG

Datadog

$40.36

-0.33 (-0.81%)

AMZN

Amazon.com

$1,752.70

15.21 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

17:55
11/18/19
11/18
17:55
11/18/19
17:55
Conference/Events
Morgan Stanley analyst to hold an analyst/industry conference call »

Managing Director &…

GVA

Granite Construction

$26.50

-0.6 (-2.21%)

17:54
11/18/19
11/18
17:54
11/18/19
17:54
Hot Stocks
Granite Construction awarded $14M airfield improvement project in California »

Granite announced it was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZS

Zscaler

$44.46

-1.37 (-2.99%)

, MSFT

Microsoft

$150.35

0.4 (0.27%)

17:51
11/18/19
11/18
17:51
11/18/19
17:51
Initiation
Zscaler, Microsoft initiated  »

Zscaler initiated with a…

ZS

Zscaler

$44.46

-1.37 (-2.99%)

MSFT

Microsoft

$150.35

0.4 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

  • 04

    Dec

  • 09

    Dec

  • 16

    Dec

OKTA

Okta

$121.21

3.76 (3.20%)

17:51
11/18/19
11/18
17:51
11/18/19
17:51
Upgrade
Okta rating change  »

Okta pullback represents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 16

    Dec

PANW

Palo Alto Networks

$248.50

1.465 (0.59%)

17:48
11/18/19
11/18
17:48
11/18/19
17:48
Initiation
Palo Alto Networks initiated  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

  • 09

    Dec

CRWD

Crowdstrike

$57.06

-2.73 (-4.57%)

, AMZN

Amazon.com

$1,752.70

15.21 (0.88%)

17:47
11/18/19
11/18
17:47
11/18/19
17:47
Initiation
Crowdstrike, Amazon.com initiated  »

Crowdstrike valuation…

CRWD

Crowdstrike

$57.06

-2.73 (-4.57%)

AMZN

Amazon.com

$1,752.70

15.21 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 05

    Dec

  • 12

    Dec

TUFN

Tufin

$17.32

-0.22 (-1.25%)

17:44
11/18/19
11/18
17:44
11/18/19
17:44
Initiation
Tufin initiated  »

DA Davidson says Tufin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$122.64

3.49 (2.93%)

17:43
11/18/19
11/18
17:43
11/18/19
17:43
Initiation
Splunk initiated  »

Splunk initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SPCE

Virgin Galactic

$9.55

-0.075 (-0.78%)

17:42
11/18/19
11/18
17:42
11/18/19
17:42
Syndicate
Breaking Syndicate news story on Virgin Galactic »

Virgin Galactic files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

VIAV

Viavi

$15.74

-0.03 (-0.19%)

17:40
11/18/19
11/18
17:40
11/18/19
17:40
Hot Stocks
Viavi files patent suits against LG Electronics, LG Innotek, Optrontec »

Viavi filed a complaint…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.